Harvard Scientists Clear Path For Study Of Early Onset Alzheimer’s Disease

Beta-amyloid plaquesResearchers at Harvard University’s Stem Cell Institute have
converted skin cells of patients with early-onset Alzheimer’s disease
into neurons that are typically affected by the disease. This is the
first time researchers have been able to study the disease in human,
rather than animal, cells, and this ability enhances the possibilities
for earlier treatments for the disease.

No Responses to “Harvard Scientists Clear Path For Study Of Early Onset Alzheimer’s Disease”

Post a Comment